Nomination Summary for Quinidine (N79313)
Nominated Substances: Quinidine
Nomination Date: 09/00/1979
Rationale: Quinidine was nominated based on the interest of the FDA in seeing this drug tested in the NCI bioassay and the lack of carcinogenicity data on this drug. Quinidine is an anti-arrhythmic and cardiotonic drug.
NTP Principles: not specified